Morgan Stanley Boosts CME Group (NASDAQ:CME) Price Target to $362.00

CME Group (NASDAQ:CME) had its price objective lifted by equities researchers at Morgan Stanley from $340.00 to $362.00 in a research note issued on Friday, MarketBeat reports. The brokerage currently has an “overweight” rating on the financial services provider’s stock. Morgan Stanley’s price target indicates a potential upside of 22.59% from the company’s current price.

Other equities research analysts have also issued research reports about the stock. The Goldman Sachs Group lifted their price objective on shares of CME Group from $266.00 to $275.00 and gave the company a “sell” rating in a report on Monday, March 16th. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a report on Thursday, February 5th. Barclays lifted their price objective on shares of CME Group from $312.00 to $344.00 and gave the company an “equal weight” rating in a report on Wednesday. UBS Group reiterated a “neutral” rating and set a $310.00 price objective on shares of CME Group in a report on Friday, February 6th. Finally, Raymond James Financial lifted their price objective on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a report on Monday, April 6th. Two investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, CME Group presently has an average rating of “Moderate Buy” and an average target price of $309.18.

CME Group Price Performance

CME stock opened at $295.30 on Friday. CME Group has a 12 month low of $251.90 and a 12 month high of $329.16. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average price of $306.36 and a 200 day moving average price of $284.56. The stock has a market cap of $105.90 billion, a PE ratio of 26.46, a P/E/G ratio of 2.88 and a beta of 0.26.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the company earned $2.52 EPS. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. Equities research analysts anticipate that CME Group will post 10.49 earnings per share for the current year.

Insider Buying and Selling at CME Group

In other news, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $300.00, for a total value of $224,400.00. Following the completion of the sale, the director owned 2,699 shares in the company, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 8,539 shares of company stock worth $2,713,821. 0.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On CME Group

Several large investors have recently modified their holdings of the business. West Family Investments Inc. raised its holdings in shares of CME Group by 1.2% in the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares in the last quarter. Asset Dedication LLC raised its holdings in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares in the last quarter. Northwestern Mutual Investment Management Company LLC raised its holdings in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group raised its holdings in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares in the last quarter. Finally, Atlatl Advisers LLC raised its holdings in shares of CME Group by 1.8% in the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Morgan Stanley raised its price target to $362 and reiterated an “overweight” view, signaling materially higher analyst conviction on CME’s revenue mix and cash returns. Morgan Stanley raise
• Positive Sentiment: TD Cowen raised its target to $340 and kept a “buy” rating — another upside-biased revision supporting upside expectations. TD Cowen upgrade
• Positive Sentiment: CME confirmed it will launch SUI futures in early May, expanding its crypto derivatives product set and opening a new institutional revenue stream. Product expansion is a tangible growth catalyst. SUI futures launch
• Neutral Sentiment: Jefferies trimmed its price target to $349 from $356 but maintained a “buy” rating — a modest downgrade that still implies upside, so impact is mixed. Jefferies PT cut
• Neutral Sentiment: Keefe, Bruyette & Woods began coverage of CME — fresh analyst attention can help liquidity and visibility but the near-term directional effect depends on published views. KBW begins coverage
• Neutral Sentiment: Short-interest data is mixed: reported short interest fell 15.6% in late March to ~4.7M shares (about 1.3% of float, ~2.3 days to cover), which reduces immediate bearish pressure; however, an April 10 reporting entry shows an anomalous “0 shares/NaN” figure, creating data uncertainty for traders. (Internal short-interest reports)
• Negative Sentiment: The White House issued an ethics warning after large, time-sensitive trading in oil futures and gains in prediction markets tied to geopolitical events. That has raised political and regulatory scrutiny of trading venues and prediction/derivatives markets — an elevated oversight risk that could lead to tighter rules or reputational scrutiny for exchanges like CME. White House ethics warning

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.